A female researcher looks through a microscope
Gastroenterology & Hepatology: Clinical & Research Programs

The faculty members at the U-M Medical School Department of Internal Medicine Division of Gastroenterology & Hepatology are involved in a wide range of basic, translational and clinical research programs that span all of the gastroenterology and hepatology sub-specialty areas.

Dedicated to Expertise

Comprehensive Pancreas Program: A program that aims to provide the best possible clinical care for patients with pancreatic disorders through patient-centered clinical care, education, innovative research and multidisciplinary collaboration.

Esophageal Disorders Program: This program integrates consultative services and endoscopic therapy, along with cutting-edge patient-oriented and translational research, to improve treatment for patients with esophageal disorders.

Functional Bowel Disorders Program: This program provides patient education and contributes to clinical research related to FBD. Our team of caring experts are equipped to help patients develop a plan for diagnosing and treating different types of bowel disorders.

Hepatology Program: This program is one of the largest and most prestigious Hepatology programs in the world. Our team has excelled in research, education, and in providing compassionate care since 1954. It includes over 18 faculty members and four advanced practice providers with world-leading expertise in a wide variety of liver diseases

Inflammatory Bowel Disease Program: An internationally recognized group of clinicians, surgeons, researchers and educators dedicated to the management of the inflammatory bowel diseases. Our specialists work to provide complete care for the complex issues associated with Crohn's disease and ulcerative colitis.

Interventional Endoscopy Program: A program that strives to provide state-of-the-art clinical care, education and research. Our faculty have contributed to the development of national guidelines on standard endoscopic practices, are part of journal editorial boards, and are often invited as speakers at national conferences.

Michigan Bowel Control Program: A multidisciplinary program that specializes in the diagnosis and treatment of defecation disorders and other disorders of the posterior pelvic floor. This expert team strives to increase understanding of the physiology of conditions, implement new therapies and technologies and improve treatment results for patients through ongoing clinical trials and basic science research.

Featured News & Stories See all news Joy Chang
Department News
Collaborative Management of EoE: Expert Insights from Joy Chang, MD, MS
Joy Chang, MD, MS, explains the importance of collaboration between gastroenterologists and allergists in eosinophilic esophagitis EoE care and praises recent ACG guidelines on disease management.
pink cells up close
Health Lab
Research links iron-mediated cell death and inflammatory bowel disease
New basic science insights into programmed cell death could offer relief for inflammatory bowel disease. The University of Michigan study reveals a connection between lipid reactive oxygen species, iron-mediated cell death and IBD.
stethoscope close up black and wood table
Health Lab
Affordable Care Act preventive services mandate key to transforming hepatitis C treatment
In an article researchers describe two potential futures: one in which 90% of hepatitis C cases in the United States are cured within five years and another in which the status quo of insufficient screening rates worsen in the absence of the ACA coverage mandate.
father and son standing together and book cover
Health Lab
One doctor’s American dream: to stop hate
Asian-American history is American history. William D. Chey shares his immigrant father’s legacy, his own experience and calls on youth to practice the values of diversity, equity and inclusion throughout their lives.
cutting board close up person cutting food with olive oil on side
Health Lab
Mediterranean diet provides symptom relief for patients with IBS in pilot study
A pilot study found that the Mediterranean diet may provide symptom relief for people with irritable bowel syndrome commonly referred to as IBS.
red cancer cell on red background
Health Lab
Researchers identify roles of key genes in colon cancer development
Researchers used mouse models and studies of colorectal cancer tissues to show that loss of SOX9 gene promotes tumor progression and the pathway it regulates can be a potential target for future treatments.